Amyloid
| Order number | NP039-0 |
|---|---|
| Name | BF-227 |
| Chemical Formula | C16H16FN3O2S |
| Molecular Weight | 333.38 |
| Purity | > 95% |
| Packaging | min. 10 mg, or as ordered |
| Purpose | Reference standard for [11C] BF-227 |
| Other name | 2-[2-(2-Dimethylaminothiazol-5-yl)ethenyl]-6-(2-fluoroethoxy)benzoxazole |
| CA index name | |
| Literature | 1. Kudo Y, Okamura N, Furumoto S, Tashiro M, Furukawa K, Maruyama M, Itoh M, Iwata R, Yanai K, Arai H. 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.J Nucl Med. 2007;48(4):553-61. 2. Kudo Y. Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease. Minim Invasive Ther Allied Technol. 2006;15(4):209-13. 3. Furumoto S, Okamura N, Iwata R, Yanai K, Arai H, Kudo Y. Recent advances in the development of amyloid imaging agents. Curr Top Med Chem. 2007;7(18):1773-89. |
